Plasma homocysteine as a metabolic risk factor for breast cancer: Findings from a case-control study in Taiwan

Breast Cancer Research and Treatment

Volumn 101, Issue 2, 2007, Pages 199-205

  Chou, Yu Ching ^a   Lee, Meei Shyuan ^a   Wu, Mei Hsuan ^a   Shih, Hsiu Lan ^a   Yang, Tsan ^b   Yu, Cheng Ping ^c   Yu, Jyh Cherng ^c   Sun, Chien An ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

B group vitamins; Breast cancer; Case control study; Homocysteine; One carbon metabolism

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOLIC ACID BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; INTRADUCTAL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOASSAY; RISK ASSESSMENT; TAIWAN; VITAMIN INTAKE;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HISTORY, 16TH CENTURY; HOMOCYSTEINE; HUMANS; MIDDLE AGED; RISK FACTORS; TAIWAN; VITAMIN B COMPLEX;

EID: 33846266172     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9278-9     Document Type: Article

References (49)

1. McCully KS (1996) Homocysteine and vascular disease. Nat Med 2:386-389
2. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050
3. The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a metaanalysis. JAMA 288:2015-2002
4. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a metaanalysis. Br Med J 325:1202
5. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators (2006)Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567-1577
6. Joosten E (2001) Homocysteine, vascular dementia and Alzheimer's disease. Clin Chem Lab Med 39:717-720
7. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346:476-483
8. Garcia A, Zanibbi K (2004) Homocysteine and cognitive function in elderly people. CMAJ 171:897-904
9. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A (2005) High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 82:627-635
10. Ray JG, Laskin CA (1999) Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: a systematic review. Placenta 20: 519-529
11. Botto LD, Yang Q (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862-877
12. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ (2001) Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 226:243-270
13. El-Khairy L, Vollset SE, Refsum H, Ueland PM (2003) Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study. Am J Clin Nutr 77:467-472
14. D'Anna R, Baviera G, Corrado F, Ientile R, Granese D, Stella NC (2004) Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction. Acta Obstet Gynecol Scand 83:155-158
15. Zhu BT (2002) On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histol Histopathol 17:1283-1291
16. Hoffman D, Cornazer W, Duerce J (1979) Relationships between tissue levels of S-adenosylmethionine, S-adenosylhomocysteine and transmethylation reactions. Can J Biochem 57:56-65
17. Young IS, Woodside JV (2000) Folate and homocysteine. Curr Opin Clin Nutr Metab Care 3:427-432
18. Yi P, Melnyk S, Pogribna M, Pogribny I, Hine R, James S (2000) Increase in plasma homocystein association with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318-29323
19. Ueland PM (1982) Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol Rev 34:223-253
20. Zhu BT, Liehr JG (1996) Inhibition of catechol O- methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin: possible role in estradiol-induced tumorigenesis. J Biol Chem 271:1357-1363
21. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ (2000) Role of quinones in toxicity. Chem Res Toxicol 13:135-160
22. Yager JD, Liehr JG (1996) Molecular mechanisms of estrogen carcinogenesis. Ann Rev Pharmacol Toxicol 36:203-232
23. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282
24. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, Speizer FE, Willett WC (1999) A prospective study of folate intake and the risk of breast cancer. JAMA 281:1632-1637
25. 12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95:373-380
26. Rohan TE, Jain MG, Howe GR, Miller AB (2000) Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 92:266-269
27. Shrubsole MJ, Jin F, Dai Q, Shu XO, Potter JD, Hebert JR, Gao YT, Zheng W (2001) Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res 61:7136-7141
28. Goodman JE, Lavigne JA, Wu K, Helzlsouer KJ, Strickland PT, Selhub J, Yager JD (2001) COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis 22:1661-1665
29. Feigelson HS, Jonas CR, Robertson AS, McCullough ML, Thun MJ, Calle EE (2003) Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 12:161-164
30. Sellers TA, Grabrick DM, Vierkant RA, Harnack L, Olson JE, Vachon CM, Cerhan JR (2004) Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? Cancer Causes Control 15:113-120
31. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM (2005) One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 65:1606-1614
32. 12 intake and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 15:443-448
33. Lee MM, Pan WH, Yu SL, Huang PC (1992) Foods predictive of nutrient intake in Chinese diet in Taiwan: total calories, protein, fat and fatty acids. Int J Epidemiol 21:922-928
34. 2, vitamin C, and calcium. Int J Epidemiol 21:929-934
35. Pan WH, Chang YH, Chen JY, Wu SJ, Tzeng MS, Kao MD (1998) Nutrition and health survey in Taiwan (NAHSIT) 1993-1996: dietary nutrient intakes assessed by 24-hour recall. Nutr Sci J 24: 11-39 (in Chinese)
36. Tan Y, Tang L, Sun X, Zhang N, Han Q, Xu M, Baranov E, Tan X, Tan X, Rashidi B, An Z, Perry AW, Hoffman RM (2000) Total-homocysteine enzymatic assay. Clin Chem 46:1686-1688
37. Willett WC, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124:17-27
38. Finkelstein JD (1998) The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 157(Suppl. 2):S40-S44
39. Bailey LB, Gregory JF III (1999) Folate metabolism and requirements. J Nutr 129:779-782
40. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128
41. Wilcken DEL, Wilcken B (1976) The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 57:1079-1082
42. Kim YI (2000) Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: A paradigm of genenutrient interactions in carcinogenesis. Nutr Rev 58:205-209
43. Homocysteine Lowering Trialists' Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82:806-812
44. Wu LL, Wu JT (2002) Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322:21-28
45. Zhu BT (2003) Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer. Int J Oncol 22:499-508
46. Yager JD (2000) Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 27:67-73
47. Liehr JG (1995) Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ Health Perspect 3:565-569
48. 12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 19:1163-1171
49. Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A (2003) Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Human Genet 11:671-678